Hangzhou Repugene Technology Co., Ltd. is a high-tech advanced biomedical research and development enterprise with the team of Dr. Haigui.
Happy news! Accurate and standard counterparts, Ripple's full score through the national tumor somatic mutation high-throughput
Today, the Rip Gene Harvesting Newsletter, Ripple Medical Laboratory conducted the "2018 National High-throughput Sequencing and Detection of Tumor Mutations in Tumors" by the Health and Medical Research Center.
The capacity verification of this inter-room quality assessment was attended by 160 laboratories from all over the country. A total of 138 laboratories returned the results of the quality assessment. A total of 6 samples were tested. Only 76 laboratories received full marks, with a score of 55.1. %(76/138).
The high-throughput sequencing of tumor somatic mutations reported by Rip gene includes: point mutation, short fragment insertion deletion, fusion gene mutation, etc. All the above-mentioned gene mutation types are detected by Rip gene.
This time, through the national inter-room quality assessment of high-throughput sequencing of tumor cells, it further demonstrates the ability and professionalism of Rip gene in high-throughput detection, and also strongly proves that Rip gene is in sample management, process control, and quality system. The comprehensive strength of testing technology and data analysis is at the leading level in the industry.
The Rip gene is the first demonstration center for the application of genetic testing technology approved by the National Development and Reform Commission. It has also obtained the qualification of the medical laboratory accredited by the National Health and Family Planning Commission and the qualification of the PCR laboratory certified by the Zhejiang Provincial Procuratorate. Passed a number of genetic testing room quality assessments by the Ministry of Health's clinical inspection center.
Ripple's genes focus on precision medicine, genetic screening, clinical research and other aspects, and continuously transform cutting-edge life science technology into clinically effective treatment and detection methods to provide accurate medical services for cancer patients and healthy people. In the future, we will not forget our original heart! We sincerely continue to participate in various inter-room quality assessment activities, constantly verifying our strength and technology, and create great achievements, responsible for every patient and customer!